Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736306 · ClinicalTrials.gov registry record
Biomarkers for Breast Cancer Risk in African American Women
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 260
- Enrollment target
NCT01736306: Completed study, sponsored by National Cancer Institute (NCI).
NCT01736306 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 260 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01736306 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 260 participants
- Enrollment target
Study Summary
Background: \- At present, women do not have very accurate tests to inform of them of their personal risk of developing breast cancer. More information on the changes associated with both benign and cancerous breast lesions will help develop better risk information. Researchers have been looking at cells found in breast milk to study genetic changes related to breast cancer. However, most of these cell samples have been collected from white women. A new study wants to collect breast milk samples from African American women for further research. Comparing the results of genetic tests will help improve understanding of breast cancer risk in all women. Objectives: \- To study genetic changes related to breast lesions, including breast cancer, in African American women. Eligibility: \- African American women at least 18 years of age who are nursing a baby and who either have had or are being considered for a breast biopsy. Design: * Participants will be screened with personal health questions. * Participants will receive a box with sterile bottles for milk collection. They will collect two breast milk samples, one from each breast. They will also fill out a questionnaire about their medical history. * The box with the samples and the questionnaire will be returned to the clinical center for study. * After the box is returned, participants will be asked to provide a copy of the biopsy report for any breast biopsies they have had. * There will be a followup phone call every year. Participants will provide health history information. This information will include whether they have been diagnosed with breast cancer in the previous year.
Primary Outcome
breast cancer risk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2012-07-23 |
| Est. Completion | 2020-03-27 |
What the finished NCT01736306 record still lists
NCT01736306 is an observational study that tracks outcomes without assigning an intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01736306 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01736306 about?
NCT01736306 is a clinical study titled "Biomarkers for Breast Cancer Risk in African American Women". Background: \- At present, women do not have very accurate tests to inform of them of their personal risk of developing breast cancer. More information on the changes associated with both benign and cancerous breast lesions will help develop better risk information. Researchers have been looking at...
What is the current status of trial NCT01736306?
This trial is currently completed. The enrollment target is 260 participants. The study started on 2012-07-23. Estimated completion is 2020-03-27.
Who is sponsoring clinical trial NCT01736306?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI